News from Hovione A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 13, 2017, 11:46 ET Hovione Announces Enrollment of First Patient in MARS, a Phase 2 Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea with its Proprietary Minocycline Topical Gel

Hovione announced today enrollment of the first patient in MARS (Minocycline Against Rosacea Study), a Phase 2 clinical study of topical...


Sep 27, 2017, 18:59 ET Hovione kündigt die Ernennung von Frédéric Kahn zum Vice President Marketing and Sales an

Hovione kündigt heute die Ernennung von Herrn Frédéric Kahn zum Vice President Marketing and Sales mit Wirkung zum 1. September 2017 an. Herr Kahn...


Sep 27, 2017, 18:58 ET Hovione annonce la nomination de Frédéric Kahn au poste de vice-président du marketing et des ventes

Hovione a annoncé aujourd'hui la nomination de M. Frédéric Kahn au poste de vice-président du marketing et des ventes, à compter du 1er septembre...


Sep 27, 2017, 09:00 ET Hovione Announces the Appointment of Frédéric Kahn as Vice President Marketing and Sales

Hovione announced today the appointment of Mr. Frédéric Kahn as Vice President Marketing and Sales, as of 1st September, 2017. Mr. Kahn was most...


May 26, 2017, 06:55 ET Hovione kündigt Beginn einer Phase-1-Studie zu HY02 an, einer proprietären sterilen Minocyclin-Salbe zur Behandlung einer Teilmenge der Uveitis anterior

Hovione gab heute den Start seiner ersten klinischen Studie bekannt. Schon bald wird Hovione mit der Rekrutierung für seine Phase-1-Studie zu HY02...


May 26, 2017, 01:35 ET Hovione annonce le début d'un essai clinique de phase 1 sur HY02, une pommade stérile propriétaire à base de minocycline pour le traitement d'un sous-groupe d'inflammation oculaire antérieure

Hovione a annoncé aujourd'hui le lancement de son premier essai clinique. Hovione commencera bientôt le recrutement pour son essai clinique de...


May 25, 2017, 09:00 ET Hovione Announces Start of Phase 1 Clinical Trial of HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation

Hovione today announced the launch of its first clinical trial. Hovione will soon initiate recruitment for its Phase 1 clinical trial of HY02, a...


Jun 16, 2016, 10:18 ET Hovione Announces the Ground-breaking Expansion Plans of Its New Jersey Facility

Hovione announced today that it held on June 8th the official groundbreaking for the expansion of its New Jersey Facility in East Windsor,...


Jun 06, 2016, 09:30 ET Hovione Opens a New Sales and Customer Support Office in Japan

Hovione is pleased to announce the opening of its new sales and customer support office in Osaka, Japan. The new office underlines the importance...


Mar 10, 2016, 08:00 ET Hovione and Vertex Partner in Continuous Manufacturing

Hovione today announced that it plans to host and operate a commercial-scale continuous manufacturing facility as part of an agreement with Vertex...


Oct 19, 2015, 09:30 ET Hovione Acquires a Formulation Plant

Hovione announced today that it is investing in specialized formulation capabilities. The first step of the plan was the acquisition of a...


Oct 12, 2015, 10:30 ET Hovione Appoints Kristine Senft Vice President, Sales and Marketing

Hovione announced today the appointment of Ms. Kristine Senft as Vice President Sales and Marketing. Ms. Senft joined Hovione on the 1st October...


Sep 29, 2015, 11:27 ET Hovione Announces the Expansion of its New Jersey Facility

Hovione announced today the expansion of its New Jersey facility in East Windsor, USA. This investment is part of the company's strategy to...


Jan 12, 2015, 10:45 ET Hovione Appoints Filipe Gaspar, PhD as Vice President R&D

Hovione today announced the appointment of Dr. Filipe Gaspar as Vice President of its Research and Development organization. Dr. Gaspar will lead...


Dec 17, 2014, 12:50 ET Successful FDA Inspection at Hovione

Hovione today announced that the U.S. Food and Drug Administration (FDA) performed a Pre-Approval Inspection to its plant in Loures, Portugal,...


Nov 27, 2014, 10:30 ET Hovione Files its First Investigational New Drug Application With the FDA

Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S. Food and Drug Administration (FDA). This...


Jul 31, 2014, 11:49 ET Successful FDA Inspection at Hovione's API Manufacturing Plant in Cork, Ireland

Hovione today announced that its API plant in Cork, Ireland has successfully passed a pre-approval inspection by the US Food and Drug...


Dec 05, 2013, 09:40 ET Hovione: New Inhalation Capsule Filling Machine Fills Market Gap

Hovione announced today the expansion of its inhalation drug product development services with the introduction of a high precision MG2 FlexaLAB...


Oct 02, 2013, 11:48 ET Another Successful FDA Inspection at a Hovione site the 12th Successful Inspection in 18 Months

Hovione's plant in Loures, Portugal has successfully passed a GMP and Postmarket Approval inspection by FDA. The inspection, carried out by Mrs....


Sep 11, 2013, 09:00 ET Hovione: EPO Grants a New Inhaler Patent

Hovione announced today that the European Patent Office has granted a patent for Hovione's XCaps, a dry powder inhaler (DPI). XCaps addresses a...


Jun 07, 2013, 09:00 ET Hovione Announces the Appointment of Justin Hughey, PhD to lead Particle Design in the USA

Hovione today announced the appointment of Dr. Justin Hughey to lead the Particle Design sciences at our site in New Jersey.  With over 30...


Apr 03, 2013, 09:00 ET Hovione Announces a Co-promotion and Collaboration Agreement with Ligand for Captisol®

Hovione today announced a co-promotion and collaboration agreement with Ligand to provide Hovione's customers efficient access to Captisol®...


Nov 28, 2012, 17:05 ET Hovione und Solvias geben Zusammenarbeit zur Verbesserung der Wirkstofflöslichkeit bekannt

Hovione und Solvias gaben heute bekannt, eine Zusammenarbeit mit dem Ziel der Entwicklung und GMP-konformen Herstellung von pharmazeutischen...


Nov 28, 2012, 12:59 ET Hovione et Solvias annoncent une collaboration pour améliorer la solubilité des médicaments

Hovione et Solvias ont annoncé aujourd'hui la mise en place d'une collaboration centrée sur le développement et l'approvisionnement...


Nov 28, 2012, 06:30 ET Hovione y Solvias anuncian una colaboración para ofrecer una solubilidad mejorada de los fármacos

Hovione y Solvias han anunciado hoy el establecimiento de una colaboración centrada en el desarrollo y suministro de GMP de co-cristales...